Cartesian Therapeutics files 8-K with corporate slide deck; no material news evident

Cartesian Therapeutics, Inc.

Slide deck titled 'Pioneering mRNA Cell Therapy for Autoimmunity' dated March 2025 furnished as Exhibit 99.1.
No financial results, pipeline updates, or guidance changes provided in the filing.
The exhibit is furnished under Regulation FD and contains no new material information.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001453687-25-000054
form_type: 8-K
ticker: RNAC
cik: 0001453687
company_name: Cartesian Therapeutics, Inc.
filed_at: 2025-03-03T23:59:59+00:00
discovered_at: 2026-05-14T18:03:03.659479+00:00
generated_at: 2026-05-25T17:25:02.922990+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.0
confidence: low
secwatch_canonical_url: https://secwatch.observer/filing/0001453687-25-000054
json_url: https://secwatch.observer/filing/0001453687-25-000054.json
markdown_url: https://secwatch.observer/filing/0001453687-25-000054.md
text_url: https://secwatch.observer/filing/0001453687-25-000054.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000054/0001453687-25-000054-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1453687/000145368725000054/rnac-20250303.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001453687-25-000054

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.